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Abstract: An emerging challenge to the scientific 
community and water industries is water contamination by 
various micro-pollutants which are pharmaceuticals, 
personal care products and endocrine disrupting chemicals. 
The main sources of these micro pollutants are waste 
waters from industrial effluent and sewage treatment 
plants. Recent advances in the knowledge have raised 
concerns about their effects on the human health and 
ecosystems. In this study, the efficiency of ferrate to 
remove low concentration of two pharmaceuticals 
(Simvastatin and Ivermectin, 10 and 100 μg/L) was 
investigated. Moreover, Zebra fish animal model was 
employed to access the acute toxicity before and after 
treatment with ferrate. Mortality, developmental changes 
(hatching, heart rate, total abnormalities count) and 
behaviour changes (swimming and activity) were recorded 
at all stages. Biochemical responses of Chloramphenicol 
acetyltransferase (CAT), Tumor necrosis factor (TNF), 
Interleukin 1 (IL-1) and B-cell lymphoma 2 (Bcl-2) were 
assessed. The study demonstrated that expression of CAT, 
TNF, IL-1 and Bcl-2 genes were affected after exposing 
zebra fish embryos to low concentration pharmaceuticals 
for 5 days (120 hours post fertilization). Simvastatin 
significantly increased the expression of anti-oxidant gene 
(CAT) and decreased the expression of Immune related 
TNF gene and apoptosis related Bcl-2 gene. Ivermectin 
showed significant change of expression of CAT and Bcl-2 
genes. Ferrate reduced the toxicity of pharmaceuticals by 
partially removing them during the treatment process.  
Keywords: Ferrate, gene study, micro-pollutants, 
Simvastatin, Ivermectin, toxicity, waste water treatment, 
zebra fish 
1. Introduction 
Pharmaceuticals, personal care products, and endocrine 
disrupting chemicals are categorized as micropollutants. 
Because of their low concentration range, from several 
μg/L to ng/L, and their raised concerns about adverse 
effects on the human health and ecosystems, micro-
pollutant is an emerging challenge to the water industries 
and scientific community. The removal of micropollutants 
and the associated toxicity study have been attracting many 
researchers world widely.  
Technologies like ozonation, nanofiltration, reverse 
osmosis and activated carbon adsorption have been widely 
studied to remove pharmaceuticals in waste water 
treatment works. Though these technologies show the 
treatment efficiency for the low concentration 
pharmaceuticals, advanced technologyies are still sought to 
enahnce the treatment efficicy to eliminate micro 
pollutnats completely. For the toxicity study, large 
numbers of new compounds, which can cause negative 
effects on aquatic organisms, have been identified by the 
environmental boards [1]. It is extremely important to 
study the toxicity of each and every compound as some 
compounds may not show immediate impact when 
exposed but may cause a cumulative effect on the longer 
exposure time. 
As one of alternative water treatment chemicals, ferrate 
has been researched in recent years to treat emerging micro 
pollutnats. Ferrate exhibits dual actions as an oxidant and 
coagulant and possesses high re-dox potential [2]. Early 
results have shown that ferrate is very effective in the 
oxidation of carbohydrates, nitrogen-containing pollutants 
and electron–rich moieties containing micropollutants [3-
9]. 
The zebrafish (Danio rerio) is the tropical freshwater 
fish belonging to Cyprinidae family. It has been used 
widely in the fields of toxicology, environmental science, 
stem cell research, regenerative medicine, oncology, 
teratology, genetics, developmental biology reproductive 
studies and evolutionary theory studies [10-15]. The 
zebrafish is a very attractive model for the research 
because of its unique features like easy maintenance in the 
labs, availability of large number of eggs, easily 
observable and transparent large eggs; embryos 
development outside from their mother body, rapid 
development, behaviour changes, very sensitive to toxic 
substances, and its genome is fully sequenced for the gene 
and biomolecular studies. 
A number of studies have reported the change in 
expression of oxidative stress genes (GST, GPx, GR and 
CAT) [16,17]  due to pharmaceutical and heavy metal 
exposures in different animal models. Ivermectın showed 
the genotoxic effect by changing ChE,  CAT, LDH and 
VTG levels [18]. Fluoxetine had a potential impact on 
zebrafish embryo by changing SERT and 5HT1A 
expression [19]. Oxytetracycline inhibited the catalase 
activity and reduced glutathione-S-transferase activity in 
adult zebrafish [20]. 
CEST2017_00330 
In this study, the efficiency of ferrate to remove 
Simvastatin and Ivermectin at two concentrations (10 and 
100 μg/L, respectively) was investigated. And also, this 
study aims to assess the toxicity of the two stated  
pharmaceuticals in the treatment effluent by  ferrate 
oxidation, using zebrafish animal model and gene 
assessment protocal involving the biochemical responses 
of oxidative stress genes (Chloramphenicol 
acetyltransferase, CAT), Tumour related gene (Tumor 
necrosis factor α, TNF-α), Inflammation-related gene 
(Interleukin 1, IL-1) and apoptosis-related gene (B-cell 
lymphoma 2, Bcl-2). 
 
2. Materials and Methods 
 
2.1 Test chemicals 
Simvastatin(≥ 98% GC grade), Ivermectin(≥ 98% GC 
grade), Potassium ferrate, Methanol, Acetonitrile, Acridine 
Orange dye, Fluorescein dye, Dimethyl sulfoxide (DMSO) 
and  qPCR kit were purchased from sigma Aldrich; SPE 
cartridge (200mg/6 mL, 1g/ 20mL) from Phenomenex. 
Deionised reagent water was generated from B114 
deıonızer 
 
2.2 Solid-phase extraction (SPE) and UV/Vis 
spectroscopy measurement  
Stock solution (10 mg/L) of pharmaceuticals was 
prepared using deionised water. The model wastewater 
samples (10 and 100 µg/L) were prepared from the stock 
solution with tap water.   
Samples were extracted using strata-X, Phenomenex 
reversed phase cartridges. Cartridges were preconditioned 
with selected solvent, followed by 5 ml of deionized water. 
After loading samples, cartridges were washed and dried 
for 15 minutes under vacuum. Finally, the sample is eluted 
with 5 ml of selected solvent. The whole extraction process 
under vacuum was at a flow rate of 5-10 ml per minute 
[4,21]. 
Calibration curves for Simvastatin and Ivermectin were 
prepared using a selective solvent (same used for elution in 
SPE). Spectra scan was run between wavelength 200 and 
1100 nm. Calibration was performed thrice. The strongest 
absorbance wavelength (λmax) was determined. Using λmax, 
the absorbance of each standard sample solution (0.1-
10mg/L) was determined and a calibration curve was 
constructed. The λmax for simvastatin (Sim) was 238 nm 
and for ivermectin (Ive) was 240 nm. The calibration 
equations with the linear regression for Sim is y=12.788x 
with correlation coefficient (R
2
) of 0.9936, and for Ive is  
y=27.029x with the R
2 
value of 0.9965, respectively, where 
y is the detected absorbance and x is the concentration of 
the pharmaceutical.  
2.3 Ferrate performance 
 
Ferrate was dissolved in 4M sodium hydroxide and the 
absorbance of resulting solution was measured at 505nm. 
The concentration of ferrate was detected using the 
equation of  (Abs/1150)×dilution factor×1000×56 gives 
mg/L of Fe(VI). 
The model phamercutial sample solutions were 
prepared to two concentrations, 10 & 100 µg/L. Ferrate 
dose (1-5 mg/L) was added and pH was adjusted to pH 4-
11 using 0.1M H2SO4 or 0.05 M NaOH. Jar test was 
performed using a six-unit stirrer (Kemiraflocculator 2000, 
kemwater) under the following steps: fast mixing (max 
rpm, 2 min) then slow mixing (40 rpm, 20 min) and finally 
sedimentation (60 min). The supernatant was collected and 
evaluated by SPE & UV/Vis spectrophotometer. By 
comparing the results before and after addition of ferrate, 
best working dose and pH were determined.  
2.4 Fish care and maintenance: 
 
Zebrafish eggs used in this study were obtained from the 
fish breeding stocks at Glasgow Caledonian University 
(ZEBTEC, Tecniplast). The fish system is maintained with 
a constant flow of conditioned water (28 ± 0.5 C,  pH 
7.5), 14:10 light/dark cycle and ventilation. The fish are 
fed with brine shrimp twice every day. The eggs were 
collected from breeding tanks and examined for 
unfertilized and abnormal eggs under a stereomicroscope 
at 4 hpf. The unfertilized, abnormal eggs were discarded. 
The healthy eggs were bleached with chlorine to prevent 
infections and incubated at 28 ± 0.5 C and used for the 
experimental purpose [8]. 
 
2.4.1 Embryotoxicity essay 
The chemical treatment process was performed at 6hpf. 
The eggs were categorized according to the number of 
treatment groups (2 pharmaceuticals 10 & 100 µg/L, 
pharmaceuticals with ferrate [2 & 3mg/L, pH 4 & 6], pH 2 
– 12 samples). Each sample group has 20 eggs and was 
exposed to 5ml of treatment sample solution in a 6 well 
plate for 120 hpf period. Each group was closely 
monitored throughout the treatment period and toxic 
endpoints were recorded and analyzed at the end of the 
120hpf period  
2.4.2 Quantitative real-time PCR assay 
The embryos after the chemical exposure at 120hpf were 
homogenized with 1 ml TRIzol® Reagent and incubated 
for 5 min at room temperature allowing complete 
nucleoprotein complex dissociation. Chloroform (200µL) 
was added to each tube, then vigorously shaken for 30 sec 
and allowed to stand for 3 min. At  4º C, all the tubes were 
centrifuged at 12000 ×g for  15 min and this results in 
phase separation of 3 layers. The top aqueous layer 
(contains RNA) was separated. To this 500µL of 
isopropanol was added,  allowed to stand for 10 min. RNA  
pellet was formed after centrifugation (12000 ×g)  for 10 
min at 4º C and remaining content was discarded. RNA 
pellet was washed with 75% ethanol by centrifuging at 
7500 ×g  for 10 min at 4º C.  The contents were allowed to 
stand for evaporation of alcohol and the RNA pellet was 
resuspended with 25µL of RNase water, incubated for 15 
minutes at 55-60 º C and concentration were measured 
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using Nanodrop spectrophotometer. The extracted RNA 
was stored at  -80 º C and was used for cDNA synthesis.  
Roche Transcriptor High Fidelity cDNA Synthesis Kit 
was used to synthesizing cDNA from RNA according to 
manufacturer protocol. The concentration of synthesized 
cDNA was measured using Nanodrop spectrophotometer. 
The gene expression was analyzed using Platinum® 
SYBR® Green qPCR SuperMix-UDG master mix and 
according to manufacturer protocol. The test was 
performed in duplicate with triplicate samples for each 
studied gene.  
Biorad CFX96
TM
 Real-Time PCR detection system was 
used for the assay. PCR conditions were: UDG incubation 
(50°C, 2 min), Taq polymerase activation (95°C for 2 min) 
and amplification (40 cycles, 95°C for 
15 sec;  55°C for 30 sec and 72°C for1 min). 
Fluorescence signal detection was measured at 72°C. 2- 
ΔΔCT
  method was used to calculate the Ct based relative 
quantification of a candidate gene by normalizing to Ct of 
the reference gene, ZF18sRNA. 
 
2.5 Statistical analysis 
Ordinary One-way ANOVA (and Nonparametric) analysis 
was used to analyze the obtained data. Dunnett’s multiple 
comparisons test was performed and 95% confidence 
interval and a significance level of 0.05 were adopted. 
 
3 Results and Discussion 
 
3.1 Performance of ferrate 
 
The removal efficeincy of pharmaceuticals by ferrate can 
be seen in Figure 1. For a ferrate dose of 2mg/L as Fe and 
for the 100µg/L samples, the removal efficiency was 30% 
for simvastatin and 19% for Ivermectin, and for the same 
ferrate dose and 10µg/L  
samples, that was 22% and 18% for Simvastatin and 
Ivermectin, respectively. The pH of the sample solution 
after addition of ferrate increased overall; from pH 7.2 to 
pH 12.2, depending on the ferrate doses applied (1 – 5 
mg/L as Fe). 
Pharmaceutical removal by ferrate was affected by the 
pH (Fig 2), where, the test samples had initial 
concentration of 100µg/L and ferrate dose employed was 
1-3 mg/L. The removal efficiency of ferrate was higher at 
pH 4 when compared to other pH conditions for all ferrate 
doses. 
3.2 Embryotoxicity study 
To study the effect of pH on the resulting toxicity, the 
sample solution (after addition of ferrate) was adjusted to 
required pH (2-12) using 0.1M H2SO4 or 0.05 M NaOH 
and tested on zebrafish eggs. Toxicity test clearly 
demonstarted that mortality rate is significant in case of pH 
2 to 4 and 10 to 12. Though there is no significant 
mortality for pH 5 and 9, there is increased mortality when 
compared to control. (Figure 3).  
 
 
Figure 1: Performance of ferrate to remove  
Simvastatin and Ivermectin (Note: sim 10 = Simvastatin 10 
µg/L; sim 100 = Simvastatin 100 µg/L and Ive 10 = 
Ivermectin 10 µg/L;  Ive 100 = Ivermectin 100 µg/L)
 
Figure 2: Influence of pH on performance of ferrate to 
remove  100µg/L of Ivermectin and Simvastatin 
 
Simvastatin has clearly exhibited toxicity at concentartion 
of 100µg/L. Mortality and total abnormalities were 
significantly raised to nearly 80% and there is significant 
decrease in hatching and heart rate when compared to the 
control. Simvastatin showed toxicity after ferrate 
treatment, suggesting incomplete removal of drug from 
sample solution. Ivermectin also showed increase in total 
abnormalities and mortality rate when compared to the 
control (Figures 4 and 5). 
 
Figure 3. Effect of pH on zebrafish embryos mortality at 
120 hpf.  
Control = Zebrafish embryo water. Test samples were 
prepared by adjusting pH with 0.1MH2SO4 or 0.05 M 
NaOH to zebrafish water. Results are shown in error bar as 
the mean ± standard deviation (SD).  








Figure 4. Effect of 100µg/L test samples (Simvastatin and Ivermectin) at pH6 on zebrafish embryos at 120 hpf before and 
after ferrate (2 and 3 mg/L) treatment.  
Control = Zebrafish embryo water. Ctrl Fe 2/3 mg/L = ferrate dose without pharmaceuticals. ctrl pH6= zebrafish embryo 
water adjusted to pH6. Results are shown in error bar as the mean ± standard deviation (SD).  








Figure 5. Represents abnormalities in zebrafish development, left: Ivermectin and right: Simvastatin. Control A = 
Zebrafish embryo water; B and C= Ivermectin 100µg/L; D, E and F= Simvastatin 100 µg/L.  D, E and F show abnormality 
in spinal cord formation; B and E shows abnormality in heart and yolksac; C, E and F show abnormality in tail formation.  
 
Figure 6. Effect of 100µg/L test samples (Simvastatin and Ivermectin) at pH6 on zebrafish embryos gene expression at 
120 hpf before and after ferrate (2 and 3 mg/L) treatment.  
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Control = Zebrafish embryo water. Ctrl Fe 2/3 mg/l = ferrate dose without pharmaceuticals. ctrl pH6= zebrafish embryo 
water adjusted to pH6. Results are shown in error bar as the mean ± standard deviation (SD).  
**** represents p<0.0001; *** represents p<0.0002; ** represents p<0.005; * represents p<0.05. 
 
3.3 Gene study 
Simvastatin at concentartion of 10 and 100µg/L changed 
the expression of oxidative stress gene (CAT), Tumour 
related gene (TNF ), apoptosis related gene (Bcl-2) and  
Inflammatory related gene (IL-1). Ivermectin showed 
significant change in the expression of CAT gene when 
compared to control (Figure 6). Ferrate at dose of 2 or 3 
mg/L didnot show any kind of toxicity 
Conclusions 
For pH 6, ferrate (VI) has shown a removal of at least 40% 
of Simvastatin and more than 20% of Ivermectin at a dose 
of 2 mg/L as Fe. Increase in dose of Ferrate (VI) didn’t 
help to increase the removal efficiency. For pH 4, the 
removal of both pharmaceuticals is more than 45%. The 
toxicity was tested using zebra fish animal model for all 
pH ranges (pH 2 - 12). The results clearly indicate the 
toxicity was in all the cases other than pH range 5-9.  
Toxicity studies clearly demonstrate that Simvastatin is 
very toxic even at a very low concentration such as 10 and 
100µg/L and can also modify the expression of oxidative 
stress gene (CAT), Tumour related gene (TNF), apoptosis 
related gene (Bcl-2) and  Inflammatory related gene (IL-1). 
Though Ivermectin is not fatal to zebrafish embryos, it 
produced significant number of abnormalities and also 
increased the expression of CAT gene, suggesting 
oxidative stress to the animal model during treatment 
procedure. 
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